ArticleOpen respiratory archives

Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Patients With Severe Lung Disease Carrying Previously Ineligible CFTR Mutations.

Laura Carrasco-Hernández et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.